Eleanor Hancock

3.3k total citations
28 papers, 2.1k citations indexed

About

Eleanor Hancock is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Eleanor Hancock has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 14 papers in Pediatrics, Perinatology and Child Health and 9 papers in Physiology. Recurrent topics in Eleanor Hancock's work include Epilepsy research and treatment (17 papers), Neonatal and fetal brain pathology (12 papers) and Tuberous Sclerosis Complex Research (9 papers). Eleanor Hancock is often cited by papers focused on Epilepsy research and treatment (17 papers), Neonatal and fetal brain pathology (12 papers) and Tuberous Sclerosis Complex Research (9 papers). Eleanor Hancock collaborates with scholars based in United Kingdom, Australia and New Zealand. Eleanor Hancock's co-authors include John Osborne, Stuart W. Edwards, Finbar O’Callaghan, Andrew Lux, Colin Kennedy, Richard Newton, Christopher Verity, Anthony L. Johnson, J. Helen Cross and J P Osborne and has published in prestigious journals such as The Lancet, The Lancet Neurology and Cochrane Database of Systematic Reviews.

In The Last Decade

Eleanor Hancock

28 papers receiving 2.0k citations

Peers

Countries citing papers authored by Eleanor Hancock

Since Specialization

Citations

This map shows the geographic impact of Eleanor Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Hancock more than expected).

Fields of papers citing papers by Eleanor Hancock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Hancock. The network helps show where Eleanor Hancock may publish in the future.

Co-authorship network of co-authors of Eleanor Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor Hancock. A scholar is included among the top collaborators of Eleanor Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor Hancock. Eleanor Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials 2022 ·European Journal of Paediatric Neurology ·John Osborne, Stuart W. Edwards, Fabienne Dietrich Alber, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Marcus Likeman, Andrew Lux, Mark T. Mackay, Andrew A. Mallick, Richard Newton, Melinda Nolan, Ronit Pressler, D. Rating, Bernhard Schmitt, Christopher Verity, Finbar O’Callaghan	4
2	The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS) 2019 ·Epilepsia ·John Osborne, Stuart W. Edwards, Fabienne Dietrich Alber, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Marcus Likeman, Andrew Lux, Mark T. Mackay, Andrew A. Mallick, Richard Newton, Melinda Nolan, Ronit Pressler, D. Rating, Bernhard Schmitt, Christopher Verity, Finbar O’Callaghan, (unknown)	65
3	Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial 2016 ·The Lancet Neurology ·Finbar O’Callaghan, Stuart W. Edwards, Fabienne Dietrich Alber, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Marcus Likeman, Andrew Lux, Mark T. Mackay, Andrew A. Mallick, Richard Newton, Melinda Nolan, Ronit Pressler, D. Rating, Bernhard Schmitt, Christopher Verity, John Osborne	196
4	An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms 2013 ·Developmental Medicine & Child Neurology ·Choong Yi Fong, John Osborne, Stuart W. Edwards, Cheryl Hemingway, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Rachel Kneen, Marcus Likeman, Andrew Lux, Santosh Mordekar, (unknown), Richard Newton, Michael Pike, Michael Quinn, Stefan Spinty, Grace Vassallo, Christopher Verity, Andrea Whitney, Finbar O’Callaghan	33
5	The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study 2011 ·Epilepsia ·Finbar O’Callaghan, Andrew Lux, (unknown), Stuart W. Edwards, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Richard Newton, Christopher Verity, John Osborne	215
6	The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification² 2010 ·Epilepsia ·John Osborne, Andrew Lux, Stuart W. Edwards, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Richard Newton, Christopher Verity, Finbar O’Callaghan	173
7	Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial 2010 ·Archives of Disease in Childhood ·(unknown), Stuart W. Edwards, Eleanor Hancock, A. L. Johnson, Colin Kennedy, Andrew Lux, Richard Newton, Finbar O’Callaghan, C M Verity, John Osborne	114
8	UK Infantile Spasms Study: neurodevelopmental outcome at 4.2 years of age 2006 ·ePrints Soton (University of Southampton) ·(unknown), Stuart W. Edwards, Eleanor Hancock, A. L. Johnson, Colin Kennedy, Andrew Lux, Richard Newton, Finbar O’Callaghan, C M Verity, J P Osborne	2
9	The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial 2005 ·The Lancet Neurology ·Andrew Lux, Stuart W. Edwards, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Richard Newton, Finbar O’Callaghan, Christopher Verity, John Osborne	287
10	Melatonin Excretion in Normal Children and in Tuberous Sclerosis Complex With Sleep Disorder Responsive to Melatonin 2005 ·Journal of Child Neurology ·Eleanor Hancock, Finbar O’Callaghan, Judie English, John Osborne	9
11	The United Kingdom Infantile Spasm Study (UKISS) comparing vigabatrin with prednisolone or tetracosactride in West Syndrome in a randomised trial: the control of infantile spasms at 14 days 2004 ·The Lancet ·(unknown), Stuart W. Edwards, Eleanor Hancock, A. L. Johnson, Catriona Kennedy, Richard Newton, (unknown), Christopher Verity, (unknown)	1
12	The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial 2004 ·The Lancet ·Andrew Lux, Stuart W. Edwards, Eleanor Hancock, Anthony L. Johnson, Colin Kennedy, Richard Newton, Finbar O’Callaghan, Christopher Verity, John Osborne	263
13	Treatment of Lennox-Gastaut syndrome 2003 ·PubMed ·Eleanor Hancock, J. Helen Cross	28
14	Treatment of infantile spasms 2002 ·The Cochrane Database of Systematic Reviews ·Eleanor Hancock, John Osborne	17
15	Lymphangioleiomyomatosis: a review of the literature 2002 ·Respiratory Medicine ·Eleanor Hancock, J P Osborne	58
16	Lymphangioleiomyomatosis and tuberous sclerosis 2002 ·Respiratory Medicine ·Eleanor Hancock, Susan Tomkins, (unknown), John Osborne	51
17	The treatment of West syndrome: a Cochrane review of the literature to December 2000 2001 ·Brain and Development ·Eleanor Hancock, John Osborne, Phillip J. Milner	30
18	Use of melatonin to treat sleep disorders in tuberous sclerosis 1999 ·Developmental Medicine & Child Neurology ·Finbar O’Callaghan, Antonia Clarke, Eleanor Hancock, Amelia R. Hunt, John Osborne	20
19	Use of melatonin to treat sleep disorders in tuberous sclerosis 1999 ·Developmental Medicine & Child Neurology ·Finbar O’Callaghan, Antonia Clarke, Eleanor Hancock, Amelia R. Hunt, John Osborne	71
20	Cognitive deficits in normally intelligent patients with tuberous sclerosis 1999 ·American Journal of Medical Genetics ·John Harrison, Finbar O’Callaghan, Eleanor Hancock, John Osborne, Patrick Bolton	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact